NASDAQ : CARL
Carlsmed, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 15.0398 USD (Oct 30, 2026, 3:23 PM EDT) · Market cap 410.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 408.18M |
| Enterprise Value | 340.87M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 27.30M |
| Shares Outstanding | 27.30M |
| Shares Change (YoY) | +496.29% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 12.21% |
| Owned by Institutions (%) | 25.37% |
| Float | 15.65M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.45 |
| Forward PS | 4.41 |
| PB Ratio | 4.83 |
| P/TBV Ratio | 4.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 5.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.84 |
| Quick Ratio | 8.31 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.98 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -66.14% |
| Return on Assets (ROA) | -28.19% |
| Return on Invested Capital (ROIC) | -32.32% |
| Return on Capital Employed (ROCE) | -36.54% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $498,386 |
| Profits Per Employee | -$286,181 |
| Employee Count | 127 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 8.85 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | +19.50% |
| 50-Day Moving Average | 15.03 |
| 200-Day Moving Average | 12.40 |
| Relative Strength Index (RSI) | 52.65 |
| Average Volume (20 Days) | 75,924 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.09M |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 4.01% |
| Short % of Float | 7.00% |
| Short Ratio (days to cover) | 13.80 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 63.30M |
| Gross Profit | 48.50M |
| Operating Income | -38.67M |
| Pretax Income | -36.35M |
| Net Income | -36.35M |
| EBITDA | -38.26M |
| EBIT | -38.67M |
| Loss Per Share | -$1.43 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 89.22M |
| Total Debt | 21.92M |
| Net Cash | 67.31M |
| Net Cash Per Share | $2.47 |
| Equity (Book Value) | 84.25M |
| Book Value Per Share | 3.09 |
| Working Capital | 97.20M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -34.15M |
| Capital Expenditures | -432,000 |
| Depreciation & Amortization | 409,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -34.58M |
| FCF Per Share | -$1.27 |
Margins
| Measure | Value |
|---|
| Gross Margin | 76.63% |
| Operating Margin | -61.09% |
| Pretax Margin | -57.42% |
| Profit Margin | -57.42% |
| EBITDA Margin | -60.44% |
| EBIT Margin | -61.09% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -496.29% |
| Shareholder Yield | -496.29% |
| Earnings Yield | -9.53% |
| FCF Yield | -8.47% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $19.40 |
| Price Target Difference | 29.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 43.78% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.84 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |